News

Northwestern Medicine and Vitestro Collaborate to Advance Autonomous Robotic Phlebotomy

Vitestro Unveils Aletta^®: The World’s First Autonomous Robotic Phlebotomy Device^™ (ARPD^™)

Vitestro Appoints Bob Gerberich as Chief Commercial Officer for North America

Vitestro Welcomes Two New Independent Board Members

Vitestro Achieves CE Marking for Autonomous Blood Drawing Device

Vitestro Shares Pivotal Trial Results at WorldLab 2024 Confirming Performance, Safety and Patient Acceptance for Breakthrough Autonomous Blood Drawing Technology

Danish hospital pre-orders 3 blood drawing devices, in first international deployment for Vitestro.

Vitestro Secures $22 Million (€20 million) for Autonomous Blood Draw Device

Vitestro secures order from Result Laboratorium for two blood drawing devices

Dutch leading St. Antonius Hospital to deploy two Vitestro blood drawing devices

Vitestro starts largest-scale clinical trial worldwide for autonomous blood drawing device with enrollment of first patients in A.D.O.P.T.